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Multiple Pigmentation Gene Polymorphisms Account
for a Substantial Proportion of Risk of Cutaneous
Malignant Melanoma
David L. Duffy1, Zhen Z. Zhao1, Richard A. Sturm2,1, Nicholas K. Hayward1, Nicholas G. Martin1 and
Grant W. Montgomery1
We have previously described the role of red hair (melanocortin-1 receptor, MC1R) and blue eye
(oculocutaneous albinism type II, OCA2) gene polymorphisms in modulating the risk of cutaneous malignant
melanoma (CMM) in a highly sun-exposed population of European descent. A number of recent studies,
including genome-wide association studies, have identified numerous polymorphisms controlling human hair,
eye, and skin color. In this paper, we test a selected set of polymorphisms in pigmentation loci (ASIP (Agouti
signalling protein, nonagouti homolog (mouse) gene), TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1),
MC1R, OCA2, IRF4 (interferon regulatory factor 4), SLC24A4 (solute carrier family 24, member 4), and SLC45A2
(solute carrier family 45, member 2)) for association with CMM risk in a large Australian population-based
case–control study. Variants in IRF4 and SLC24A4, despite being strongly associated with pigmentation in our
sample, did not modify CMM risk, but the other six did. Three single nucleotide polymorphisms (rs28777,
rs35391, and rs16891982) in the MATP gene (SLC45A2) exhibited the strongest crude association with risk, but
this was attenuated to approximately the same effect size as that of a MC1R red hair color allele by controlling
for ancestry of cases and controls. We also detected significant epistatic interactions between SLC45A2 and
OCA2 alleles, and MC1R and ASIP alleles. Overall, these measured variants account for 12% of the familial risk of
CMM in our population.
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INTRODUCTION
Cutaneous malignant melanoma (CMM) is a common cancer
in the fair-skinned population of tropical and subtropical
Queensland, Australia, with an estimated lifetime risk of 5%
(Queensland Cancer Registry, 2008). Within the fairer
skinned populations, risk varies with the degree of paleness
as well as with other pigmentation phenotypes, such as hair
and eye color, all of which are strongly genetically
determined.
We have previously described association between variants
in the pigmentation genes encoding the melanocortin-1
receptor (MC1R) (Palmer et al., 2000; Box et al., 2001) and
the human melanocyte-specific P-protein (oculocutaneous
albinism type II, OCA2) with CMM risk (Sturm et al., 2008).
A number of recent genome-wide association studies have
characterized variants in both known pigmentation pathways
(TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1), and
SLC45A2 (solute carrier family 45, member 2)) (Sulem et al.,
2007; Sulem et al., 2008) and previously unknown (IRF4
(interferon regulatory factor 4) and SLC24A4 (solute carrier
family 24, member 4)) (Sulem et al., 2007; Han et al., 2008)
genes that influence pigmentation, and one study has
reported on associations with CMM (Gudbjartsson et al.,
2008). Association with both pigmentation (Sulem et al., 2008)
and CMM risk (Brown et al., 2008; Gudbjartsson et al., 2008)
has also been reported for variants in a region of chromosome
20 fairly close to the human homologue of the mouse Agouti
gene (ASIP).
Variants in many of these genes exhibit significant
differences in frequency, and underlie the pigmentation
differences, between different ethnic groups. It is important,
therefore, to differentiate between disease associations due to
a direct genotype–phenotype relationship, and those due to
confounding by ancestry.
Here, we replicate and extend association results with
CMM to MC1R, OCA2, TYR (OCA1), TYRP1 (OCA3), IRF4,
SLC24A4, SLC45A2 (MATP, OCA4), and ASIP, and examine
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the nature of interaction between these loci on disease risk in
a large sample from a population at high environmental and
genetic risk of melanoma.
RESULTS
There were 1,738 CMM cases and 4,517 controls. Ancestry
and coloring for the sample are shown in Table 1. Differences
between cases and controls are in the expected direction, as
reported previously for this sample (Palmer et al., 2000), with
cases tending to have lighter colored eyes and hair.
Participants were genotyped at up to 161 single nucleotide
polymorphisms (SNPs) across the gene regions of interest
(Supplementary Table 1). Table 2 shows case and control
allele frequencies and Hardy–Weinberg equilibrium tests for
selected SNPs. A number of SNPs exhibited extreme Hard-
y–Weinberg disequilibrium, but as the chosen SNPs are
located in pigmentation loci that are known to be highly
informative for coloring and ancestry, it could be shown that
the disequilibrium was due to ethnic stratification of the
sample rather than to genotyping error (see Supplementary
Table 2).
One or more of the SNPs selected in each gene region
could be shown to be associated with skin, hair, or eye color
(Table 3), and in the subsequent analyses, we only present
results for association with CMM for the polymorphisms most
penetrant for pigmentary characteristics from each gene. In
keeping with the selection criteria, a number of these SNPs
were also strongly associated with the reported ancestry (see
Supplementary Table 2). Among the CMM cases with
ancestry information, only 2.7% reported other than 100%
Northern European ancestry, as compared with 13.5% of
the control sample. To control these effects on CMM
association analyses given below, we report analyses on the
subset of 1,438 cases and 3,098 controls reporting four
grandparents of Northern European ancestry. We found that
further inclusion of an ancestry indicator for English, Scottish/
Welsh/Irish, and continental Europe as a covariate did not
detect finer levels of ethnic confounding on CMM associa-
tion. Interestingly, rs12203592 (in IRF4) did exhibit signifi-
cant allele frequency differences between controls from
continental Europe, England and Scotland, Ireland and
Wales, but these could be safely ignored given that this
locus does not exhibit significant association with CMM (see
below).
In univariate analyses, MC1R, ASIP, TYRP1, (IRF4), and
SLC45A2 SNPs were the markers most strongly associated
with CMM risk in terms of crude risk (Table 4). Given the star-
shaped genealogy of MC1R red-hair-associated haplotypes
(that is, all these coding variants are in complete negative
linkage disequilibrium; in our population we have observed
only three haplotypes with more than one coding variant
present), we have recoded MC1R haplotypes as ‘‘R’’ (high red
hair penetrance: rs1805006 (D84E), rs11547464 (R142H),
rs1805007 (R151C), rs1805008 (R160W), and rs1805009
(D294H)) and ‘‘r’’ (low red hair penetrance: rs1805005,
rs2228479, and rs885479) (Sturm et al., 2003) for this and
subsequent analyses. On restricting the case–control analysis
only to individuals reporting all four grandparents to be of
Northern European ancestry, the significant predictors of
CMM risk were four ‘‘R’’ SNPs in MC1R (rs1805007,
rs1805008, rs1805006, and rs11547464); the three SLC45A2
SNPs; rs1126809 in TYR; and rs4911442 in the region of
ASIP. In the case of SLC45A2, the three SNPs were in very
strong disequilibrium, and the noncoding SNPs, rs35391 and
rs28777, were not significant melanoma risk predictors in
multivariate logistic regression models after adjusting for
rs16891982.
When we further adjusted for hair, eye, and skin color,
several SNPs exhibited a persistent association, suggesting
that they act as mediating variables (Table 4) between
ancestry and melanoma risk. The TYR coding SNP,
rs1126809, remained important, but rs12913832 in OCA2
(a regulatory SNP actually located in an intron of the adjacent
HERC2 gene, but the main determinant of blue eye color,
Sturm et al., 2008) and the TYRP1 SNPs were less impressive
as CMM risk factors. The effect of OCA2*R419Q was
relatively small in its own right. When we combine the
strongest associated SNPs from TYR, SLC45A2, OCA2,
MC1R, and ASIP in a multivariate logistic regression (Table 5),
this gives a Nagelkerke R2 index¼0.059. For comparison, a
regression including eye, skin, and hair color obtained
R2¼ 0.048, and supplementing this with the genotype data
increased the R2 to 0.08. As logistic regression R2-values are
difficult to interpret (Nagelkerke 1991), we also present
locus-specific sibling recurrence risk ratios (lS). Under the
usual multiplicative model assumption, these can be multi-
plied to give a total contribution of 1.14 to the sibling
recurrence risk. We can calculate the equivalent contribution
of measured pigmentation phenotype (skin, hair, and eye
color) at 1.37, so that the current SNPs explainB43% of the
effects of pigmentation on familial risk (log(1.15)/log(1.37))
and B15% of the total observed sibling risk lS¼2.49
estimated previously in our population (Do et al, 2004).
Table 1. Descriptive statistics for genotyped CMM
cases and controls (percentages are of total with data
for that phenotype, except for ancestry)
CMM Cases Controls
All four grandparents of
Northern European ancestry
1,483 (93.0%) 3,098 (83.3%)
Blue/grey eyed 758 (43.7%) 1,838 (44.7%)
Green/hazel eyed 692 (39.9%) 1,212 (29.5%)
Brown/black eyed 283 (16.3%) 1,059 (25.8%)
Blond hair 419 (24.1%) 569 (23.7%)
Light brown hair 653 (37.6%) 1,391 (33.9%)
Red hair 193 (11.1%) 217 (5.3%)
Dark brown hair 402 (23.1%) 1,705 (41.5%)
Black hair 71 (4.1%) 226 (5.5%)
Male 967 (47.8%) 2,129 (47.2%)
Total genotyped individuals 1,738 4,517
CMM, cutaneous malignant melanoma.
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In analyses including pairwise interactions, we observed
an interaction only between OCA2*R419Q and rs1126809
(P¼0.01, Supplementary Table 3), although there was a
suggestive pattern of interaction between MC1R and ASIP
genotypes and CMM, which mirrored a highly significant
interaction between these loci in their effects on the red hair
color (Table 6).
As we noted elsewhere (Brown et al., 2008), a number of
SNPs spread over the region around ASIP exhibit association
with CMM, and the analyses above have concentrated on
rs4911442 only because it is genotyped in more controls
than the other peak SNPs. The pattern of linkage disequili-
brium around ASIP is quite complex, with ‘‘hotspots’’ just
distal to the gene and 70 kbp proximal (see Figure 1), and
the pattern of individual SNP association with CMM and with
red hair color is bimodal, dipping rather than rising over
ASIP.
Examining haplotypes that are comprised of 31 SNPs
spanning from rs17305657 to rs1885120 (a distance of
1.77 Mbp) revealed that the commonest haplotype (present in
4% of controls) is significantly increased in CMM cases
(7.3%, odds ratio¼1.89; see Supplementary Table 4). This
haplotype is tagged by the SNPs that are most strongly
individually associated with CMM (including rs4911442).
When analysis is restricted just to six tagging SNPs, there are
eight haplotypes present at greater than 1% study frequency,
one (78% of control samples) being significantly increased in
controls and three (3.8%, 3.9%, 0.6%) increased in cases
(global w2¼47.2, d.f.¼14, P¼ 2105). The latter three
share only the distal three markers in common; hence the
most likely location for the susceptibility locus lies down-
stream to ASIP.
Using a publicly available US population genome-wide
association studies data set (Simon-Sanchez et al., 2007), we
were able to show that the peak CMM SNP set described by
Gudbjartsson et al. (2008) was in strong linkage disequili-
brium with rs4911442, despite being 600 kbp distant
(P¼41013). Specifically, an individual carrying the G-A
risk haplotype defined by Gudbjartsson et al. (2008) had a
50% probability of carrying the rs4911442*C on that
haplotype, whereas the other three haplotypes were asso-
ciated with rs4911442*T in 99% of cases.
Table 2. Allele frequencies and tests of Hardy–Weinberg equilibrium for pigmention-associated polymorphisms in
Australian CMM cases and controls
Controls CMM Cases
Chr Locus/variant rsID Alleles N MAF HWE-P N MAF1 HWE-P2
5 SLC45A2 i31 rs35391 A (G) 4,107 0.0321 0.1527 1,708 0.0088 1.0000
5 SLC45A2 i3 rs28777 G (T) 4,111 0.0429 0.0001 1,716 0.0118 1.0000
5 SLC45A2*F374L rs16891982 G (C) 4,032 0.0518 0.0000 1,731 0.0133 0.0346
6 IRF4 i4 rs12203592 T (C) 4,113 0.2259 0.8696 1,727 0.2107 0.0264
9 TYRP1 rs1408799 T (C) 4,110 0.3275 0.0766 1,703 0.2877 0.0980
9 TYRP1 i6 rs2733832 C (T) 4,098 0.4119 0.0492 1,732 0.3753 0.1514
11 TYR i3 rs10765198 C (T) 4,103 0.3138 0.1739 1,721 0.3405 0.2930
11 TYR*S192Y rs1042602 A (C) 4,112 0.3486 0.7407 1,728 0.3390 0.0150
11 TYR*R402Q rs1126809 A (G) 4,102 0.3061 0.7688 1,731 0.35 0.08
14 SLC24A4 rs12896399 T (G) 4,102 0.4493 0.2857 1,705 0.4564 0.1512
15 OCA2*R419Q rs1800407 A (G) 3,996 0.0798 0.6061 1,052 0.1042 1.0000
15 HERC2 i86 rs12913832 T (C) 4,102 0.2315 0.0190 1,747 0.2116 0.1133
16 MC1R*V60L rs1805005 T (G) 2,849 0.1212 0.6061 1,945 0.1181 0.2041
16 MC1R*D84E rs1805006 T (G) 2,851 0.0111 0.4651 1,947 0.0194 0.0008
16 MC1R*V92M rs2228479 A (G) 1,882 0.0961 0.0794 1,286 0.0995 0.5023
16 MC1R*R142H rs11547464 A (G) 1,805 0.0044 0.4878 1,114 0.0198 1.0000
16 MC1R*R151C rs1805007 T (C) 1,876 0.1096 0.9091 1,126 0.1567 0.5223
16 MC1R*R160W rs1805008 T (C) 2,848 0.0697 0.6061 1,947 0.1122 0.8365
16 MC1R*R163Q rs885479 A (G) 1,896 0.0466 0.7407 1,291 0.0476 0.6452
16 MC1R*D294H rs1805009 C (G) 2,851 0.0266 0.9091 1,947 0.0328 1.0000
20 ASIP region2 rs4911442 C (T) 4,089 0.1306 0.3003 1,745 0.1848 0.2003
ASIP, Agouti signaling protein; CMM, cutaneous malignant melanoma; HWE-P, Hardy–Weinberg Equilibrium test P-value; IRF4, interferon regulatory factor
4; MAF, minor allele frequency; MC1R, melanocortin-1 receptor; OCA2, oculocutaneous albinism type II; SLC45A2, solute carrier family 45, member 2;
SLC24A4, solute carrier family 24, member 4; TYR, tyrosinase; TYRP1, tyrosinase-related protein 1.
1The letter i denotes intron, so HERC2 i86 denotes the 86th intron of the HERC2 gene.
2Actually present in intron of NCOA6, 500 kbp distal to ASIP.
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DISCUSSION
This paper attempts to address two topics. The first is to
confirm and quantify the overall contribution of currently
recognized pigmentation loci to variation in risk of cutaneous
melanoma. Second, we expand the evidence of the recently
recognized association between SNPs near ASIP and CMM,
and attempt to reconcile results from different studies
(Gudbjartsson et al. 2008; Brown et al., 2008).
We have replicated association of SNPs at our chosen loci
MC1R, OCA2, ASIP, SLC45A2, SLC24A4, TYR, TYRP1, and
IRF4 with skin, hair, and eye color, and shown that most of
these SNPs are also significant predictors of CMM risk in our
population. As some SNPs are not genotyped in all subjects,
the data set suitable for multivariate analysis is reduced;
hence the confidence intervals around simultaneously
adjusted effect sizes are broader than that for (most of) the
univariate analyses. The pattern is broadly consistent with
multiplicative epistasis, with only weak evidence for non-
multiplicative interactions. The combination of SNPs in the
five associated loci (MC1R, SLC45A2, OCA2, TYR, and ASIP)
explains roughly one-third to one-half of the variation in risk
due to observed pigmentation phenotype. Pigmentation
phenotype itself explains approximately one-third of the
familial aggregation of melanoma. By contrast, the high-
penetrance CDKN2A mutations segregating in families with
multiple cases of melanoma explain only 0.1% of recurrence
risk in the total population. This is because they are extremely
rare and involved in 0.2% of all Queensland melanoma cases
(Aitken et al., 1999), with an allele frequency of B5 106.
Attributable risk is another measure of the importance of a
risk locus, but is not completely satisfactory, in that genotypes
that are rare in our population may offer the lowest absolute
reduction in risk (for example, the rare protective allele in
SLC45A2).
Table 3. Results of association analyses of selected SNPs with skin, eye, and hair color in individuals with all four
grandparents of Northern European ancestry
Locus/variant SNP
Allelic odds ratio for
pale skin (P-value)
Allelic odds ratios for blue
eye color (P-value)
Allelic odds ratios for
light hair (P-value)1
SLC45A2 i3 rs35391 3.42 (o1.0e-5) 2.60 (0.001) 5.34 (o1.0e-5)
SLC45A2 i3 rs28777 4.31 (o1.0e-5) 2.56 (0.017) 6.30 (o1.0e-5)
SLC45A2*F374L rs16891982 3.80 (o1.0e-5) 2.50 (o1.0e-5) 6.72 (o1.0e-5)
IRF4 i4 rs12203592 1.63 (o1.0e-5) 1.28 (0.0017) 2.22 (o1.0e-5)
TYRP1 rs1408799 1.06 (0.2985) 1.22 (0.018) 1.22 (o1.0e-5)
TYRP1 i6 rs2733832 1.05 (0.3333) 1.22 (0.007) 1.22 (o1.0e-5)
TYR i3 rs10765198 1.25 (0.0015) 1.33 (o1.0e-5) 1.01 (0.77)
TYR*S192Y rs1042602 1.06 (0.11) 1.04 (0.57) 1.13 (0.13)
TYR*R402Q rs1126809 1.27 (o1.0e-5) 1.43 (o1.0e-5)
SLC24A4 rs12896399 1.17 (0.061) 1.85 (o1.0e-5) 1.45 (o1.0e-5)
OCA2*R419Q rs1800407 1.10 (0.59) 2.37 (o1.0e-5) 1.21 (0.14)
HERC2 i86 rs12913832 1.74 (o1.0e-5) 30.77 (o1.0e-5) 2.95 (o1.0e-5)
MC1R*V60L rs1805005 1.01 (0.85) 1.00 (0.80) 1.13 (0.008)
MC1R*D84E rs1805006 5.19 (o1.0e-5) 1.23 (0.61) 1.74 (0.041)
MC1R*V92M rs2228479 1.38 (0.024) 1.06 (0.61) 1.17 (0.016)
MC1R*R142H rs11547464 1.31 (0.54) 1.03 (0.71) 1.28 (0.74)
MC1R*R151C rs1805007 2.57 (o1.0e-5) 1.09 (0.94) 2.13 (o1.0e-5)
MC1R*R160W rs1805008 1.72 (o1.0e-5) 1.12 (0.17) 1.82 (o1.0e-5)
MC1R*R163Q rs885479 1.10 (0.53) 1.21 (0.15) 1.12 (0.014)
MC1R*D294H rs1805009 2.88 (o1.0e-5) 1.16 (0.74) 1.68 (o1.0e-5)
MC1R ‘‘R’’2 3.70 (o1.0e-5) 1.09 (0.43) 2.30 (o1.0e-5)
MC1R ‘‘r’’ 3 1.84 1.10 1.26
ASIP region rs4911442 1.43 (o1.0e-5) 1.01 (0.87) 1.28 (o1.0e-5)
ASIP, Agouti signaling protein; CMM, cutaneous malignant melanoma; IRF4, interferon regulatory factor 4; MC1R, melanocortin-1 receptor; OCA2,
oculocutaneous albinism type II; SLC45A2, solute carrier family 45, member 2; SLC24A4, solute carrier family 24, member 4; SNP, small nucleotide
polymorphisms; TYR, tyrosinase; TYRP1, tyrosinase-related protein 1.
1Light hair=blond, light brown, red.
2High-penetrance red hair color MC1R haplotype: variant at D84E, R142H, R151C, R160W, or D294H.
3Low-penetrance red hair color MC1R haplotype: variant at V60L, V92M, or R163Q.
www.jidonline.org 523
DL Duffy et al.
Multiple Pigmentation Gene Polymorphisms
This is only the third study reporting an association
between SLC45A2 and CMM. Fernandez et al. (2008)
genotyped the coding polymorphism rs16891982 (F374L) in
a collection of Spanish CMM cases and controls, whereas
Guedj et al. (2008) report results from a French case–control
study. In keeping with our findings, the minor (L374) allele
was protective (7% frequency in Spanish cases and 16%
frequency in Spanish controls; 4% and 10% in the French
sample). This protective allele is associated with olive and
dark skin, and hence is least common in Northern European
populations (1.7% in the Utah-derived CEU HapMap
sample), more common in Southern Europeans, but is fixed
in African and most Asian populations (Yuasa et al., 2006). In
our Australian sample, examination of the three SNP
haplotypes and logistic regression analysis showed that
rs16891982 is the SNP most strongly associated with
melanoma risk in our population.
The variant in the TYR most strongly associated with
CMM risk by Gudbjartsson et al. (2008) was rs1126809
(R402Q). We found a significant association with rs1126809,
and any association with the intronic SNP rs10765198
disappeared in multivariate models in which rs1126809
was included as a covariate. The Q402 variant form of TYR
has 25% of the catalytic activity of the R402 form at 37 1C
(Tripathi et al., 1991), and causes autosomal recessive
ocular albinism when co-occurring with more penetrant
OCA mutations in compound heterozygote form (Fukai et al.,
1995; Hutton and Spritz, 2008). It is therefore a strong
candidate for the causative risk variant in this gene.
Similar to Gudbjartsson et al. (2008), we did not detect
any association between rs1042602 (TYR*S192Y) and CMM
in our Australian sample, even though those authors did
detect an association with freckling in their Scandinavian
sample.
Table 4. Results of association analyses of individual pigmentation-associated SNPs and risk of CMM
Allelic odds ratio for CMM (P-value)
Locus/variant SNP All cases and controls
Subset: 100% Northern
European ancestry
Same subset, adjusted
for hair, eye and skin color1
Same subset, adjusted
for MC1R genotype
SLC45A2 i3 rs35391 3.71 (o1.0e-4)2 2.49 (0.0014) 1.53 (0.11) 1.68 (0.16)
SLC45A2 i3 rs28777 3.75 (o1.0e-4) 2.37 (0.0012) 1.68 (0.045) 2.28 (0.0028)
SLC45A2*F374L rs16891982 3.44 (o1.0e-4) 2.86 (o1.0e-5) 1.68 (0.0001) 1.68 (0.0004)
IRF4 i4 rs12203592 1.04 (0.32) 1.18 (0.0075) 1.05 (0.45) 1.03 (0.77)
TYRP1 rs1408799 1.20 (0.0007) 1.14 (0.0117) 1.166 (0.014) 1.06 (0.56)
TYRP1 i6 rs2733832 1.16 (0.0018) 1.12 (0.0243) 1.121 (0.025) 1.06 (0.33)
TYR*R402Q rs1126809 1.20 (0.002) 1.13 (0.001) 1.19 (0.0059) 1.37 (0.0004)
TYR*S192Y rs1042602 1.05 (0.30) 1.10 (0.10) 1.14 (0.040) 1.17 (0.041)
SLC24A4 rs12896399 1.11 (0.24) 1.12 (0.37) 1.07 (0.30) 1.09 (0.24)
OCA2*R419Q rs1800407 1.31 (0.004) 1.18 (0.20) 1.23 (0.096) 1.35 (0.022)
HERC2 i86 rs12913832 1.15 (0.042) 1.06 (0.51) 1.20 (0.078) 1.21 (0.048)
MC1R*V60L rs1805005 1.01 (0.80) 1.02 (0.87) 1.02 (0.83) —
MC1R*D84E rs1805006 1.61 (0.013) 2.15 (0.004) 1.58 (0.10) —
MC1R*V92M rs2228479 1.07 (0.53) 1.12 (0.42) 1.08 (0.62) —
MC1R*R142H rs11547464 2.25 (0.055) 3.33 (0.014) 3.85 (0.011) —
MC1R*R151C rs1805007 1.58 (7.0e-4) 1.39 (0.0042) 1.00 (0.99) —
MC1R*R160W rs1805008 1.68 (o1.0e-4) 1.53 (o1e-4) 1.29 (0.092) —
MC1R*R163Q rs885479 1.15 (0.54) 1.04 (0.99) 1.04 (0.83) —
MC1R*D294H rs1805009 1.42 (0.019) 1.27 (0.87) 1.01 (0.87) —
MC1R ‘‘R’’3 1.65 (o1e-5) 1.56 (o1e-5) 1.12 (0.1481)
MC1R ‘‘r’’ 4 1.10 1.08 0.95
ASIP region rs4911442 1.49 (o1e-5) 1.46 (o1e-5) 1.32 (8.0e-4) 1.39 (0.0037)
ASIP, Agouti signaling protein; CMM, cutaneous malignant melanoma; IRF4, interferon regulatory factor 4; MC1R, melanocortin-1 receptor; OCA2,
oculocutaneous albinism type II; SLC45A2, solute carrier family 45, member 2; SLC24A4, solute carrier family 24, member 4; SNP, small nucleotide
polymorphisms; TYR, tyrosinase; TYRP1, tyrosinase-related protein 1.
1Hair color encoded as four-category categorical variable (fair, light brown, red, and dark); eye color as three-category ordinal trait; and skin color as three-
category ordinal trait.
2Bold values denote P value o 103 (equivalent to Po0.04 after a Bonferroni’s correction for 40 tests).
3High-penetrance red hair color MC1R haplotype: variant at D84E, R142H, R151C, R160W, or D294H.
4Low-penetrance red hair color MC1R haplotype: variant at V60L, V92M, or R163Q.
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In the case of OCA2, we found that the SNP (rs12913832),
most strongly associated with blue eye color in our sample
(Sturm et al., 2008), was not associated with CMM, especially
after adjusting for ancestry. Rather, the less common coding
mutation R419Q (rs1800407) was a significant risk factor,
notably in the multivariate analysis adjusted for other
pigmentation loci. This association has also been seen in a
Spanish data set (Fernandez et al., 2009) with similar effect
sizes. In the French case–control study of Jannot et al. (2005),
R419Q was not a significant risk factor for melanoma, but the
nearby R305W and neighboring intronic SNPs were. The
R305W and R419Q variants are in complete linkage
disequilibrium in our population. The OCA2 variants
screened by Gudbjartsson et al. (2008) were not associated
with CMM.
The TYRP1 (OCA3) variants we genotyped have been
previously shown to be associated with eye and hair color
(Sulem et al. 2008), and with CMM risk (Gudbjartsson et al.,
2008). We confirmed these associations and effect size
estimates. These variants differ significantly in frequency
between the main HapMap ethnic samples, and we could
show a gradient with a proportion of Northern European
ancestry paralleling hair and eye color. We did not detect
specific interactions between TYR and TYRP1 in their effects
on melanoma risk or on pigmentation phenotypes.
The two recent reports of association of SNPs located in
the region of ASIP with CMM risk (Gudbjartsson et al., 2008;
Brown et al., 2008) implicated widely separated SNPs. We
observed that the association of CMM with the ASIP region
closely paralleled that with red hair color, and seems to be
largely due to a single long (B1.8 Mb) haplotype that
straddles a number of haplotype block boundaries. This is
likely to represent the effects of selection along with a
relatively recent origin, as has been observed around other
pigmentation loci (Barreiro et al., 2008), given that this
particular haplotype is also associated with lighter hair and
skin color.
Given the role of ASIP as an antagonist of the melano-
cortin pathway, it seems biologically plausible that there
would be an interaction between MC1R genotype and ASIP
genotype. For red hair color, this was markedly so, with the
rs4911442*C allele being roughly equivalent to an ‘‘r’’ MC1R
haplotype. This is most easily seen by comparing the
penetrances of the joint ‘‘R/w; C/T’’ genotype with the ‘‘R/r;
T/T’’ genotype, and in the linear dose–response relationship
between number of rs4911442*C alleles on an ‘‘R/r’’ back-
Table 5. Multivariate analysis of CMM versus five polymorphic pigmentation loci, and pigmentation phenotype in
individuals of 100% Northern European ancestry (1,062 cases, 1,262 controls)
Variant
Allelic odds ratio
(no covariates)
Allelic odds ratios
(pigmentation as covariate)
Locus-specific sibling recurrence
risk ratio1 (attributable risk2)
MC1R ‘‘r’’ 1.10 (0.94–1.27)
1.09 (0.94–1.27)
1.047 (19.4%)
MC1R ‘‘R’’ 1.74 (1.49–2.01)
1.46 (1.24–1.72)
1.047 (19.4%)
rs16891982*C
SLC45A2
2.47 (1.51–4.07)
2.04 (1.27–3.40)
1.058 (90.6%)
rs1800407*A
OCA2*R419Q
1.32 (1.09–1.61)
1.34 (1.10–1.64)
1.008 (5.1%)
rs1126809*A
TYR*Q402R
1.24 (1.09–1.41)
1.18 (1.04–1.34)
1.010 (8.0%)
rs4911442*C
ASIP
1.44 (1.23–1.69)
1.40 (1.19–1.65)
1.016 (10.8%)
Hair color3 —
0.88, 1.50, 0.72, 0.59 (P=1.8e-5)4
1.374
Skin color5 —
0.98, 0.63 (P=0.007)4
Eye color6 —
1.22, 1.05 (P=0.10)4
Total model R2 5.9% 8.3%
ASIP, Agouti signaling protein; CMM, cutaneous malignant melanoma; MC1R, melanocortin-1 receptor; OCA2, oculocutaneous albinism type II; SLC45A2,
solute carrier family 45, member 2; TYR, tyrosinase.
1Assuming a lifetime melanoma risk of 5.2% in the Queensland population.
2Proportional reduction in disease rate if entire population carried lowest risk genotype.
3Five categories (fair, light brown, red, dark brown, and black); reference category, fair.
4P-value from sequential likelihood ratio test.
5Three categories (light, medium, and dark); reference category, light.
6Three categories (blue/grey, green/hazel, and brown/black); reference category, blue/grey.
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ground (Table 6). In the same fashion, MC1R ‘‘R’’ haplotypes
were dominant to rs4911442*C. Therefore, ASIP is a red hair
color locus, in the same way as MC1R. In keeping with this,
rs4911442 genotype was a significant predictor of facial
freckling (P¼0.0001), as noted by others (Gudbjartsson
et al., 2008). A similar pattern was observed for CMM, but did
not reach formal statistical significance. The association
signal for red hair color and CMM across chromosome 20 did
track quite strongly, so we expect that the epistatic pattern
seen for these two loci with respect to hair color would also
be demonstrable for CMM given a larger sample size.
An interesting negative finding in this study is the absence
of an association between IRF4 genotype and melanoma risk,
despite the very strong evidence for association of this locus
with skin coloring in this and other studies (Han et al., 2008;
Sulem et al., 2008). This was also noted by Gudbjartsson
et al. (2008), and is in some ways the obverse of our previous
observation (Palmer et al., 2000) that some pigmentation loci,
such as MC1R, seem to affect CMM risk by pathways other
than that mediated by measurable changes in skin coloring or
tanning ability. Here, we observe an effect on coloring,
which one would expect to significantly influence response
of the organism to exposure to ultraviolet light, but appears
neutral with respect to CMM risk. In the case of OCA2, we
and others have previously described how a single SNP
rs12913832 strongly predicts eye color (Sturm et al., 2008;
Kayser et al., 2008; Eiberg et al., 2008), but has little or no
effect on CMM risk. We do see an effect of another OCA2
polymorphism rs1800407 on CMM risk, but this is less
impressive in terms of statistical significance.
A peculiarity of these analyses is that most of these
pigmentation loci markedly differ in allele frequencies
between different ethnic groups, in a way that parallels the
differences in CMM rates between these groups. The simplest
hypothesis, given that we have shown that all the selected
variants are associated with pigmentation, is that these
variants underlie ethnic variation in CMM risk. To definitively
exclude ethnic confounding as a cause of the observed
association between ancestry informative variants and
disease risk, we would need either a cohort design, in which
we could show that the rate of CMM in carriers of all low-risk
variants is comparable with that seen in ethnic groups of
known low ‘‘intrinsic’’ risk, or a family-based design, in
which we could also show linkage of these variants.
Unfortunately, the age of onset of CMM in our sample and
sampling design means that we cannot pursue the latter
strategy, although we can show significant transmission-
disequilibrium test results for pigmentation phenotypes, such
as skin coloring.
In conclusion, the variants in pigmentation genes that we
describe explain B40% of the variation in familial risk of
melanoma ascribable to phenotypes, such as skin, hair, and
eye color. In the cases of TYR, SLC45A2, OCA2, and MC1R,
it is likely that the major causative risk variants have been
identified, but this is still open for ASIP, and other minor risk
variants at all loci await characterization.
MATERIALS AND METHODS
Study participants
Cutaneous malignant melanoma cases were a stratified sample of all
cases of CMM diagnosed in the state of Queensland between the
period 1982 and 1990, as described in detail elsewhere (Baxter
et al., 2008). These individuals were originally studied from 1991 to
1994, but were recontacted and interviewed between 2002 and
2004.
The controls for the present analysis came from the Brisbane
Twin Nevus Study. As described in detail elsewhere (Sturm et al.,
2008), adolescent twins, their siblings, and parents have been
recruited over 16 years into an ongoing study of genetic and
environmental factors contributing to the development of pigmented
nevi and other risk factors for skin cancer. The proband twins are
recruited at the age of 12 years through schools around Brisbane,
Australia, and followed up at the age of 14 years. All controls are
screened to be unaffected by CMM. The sample is overwhelmingly
(495%) of Northern European origin (mainly Anglo-Celtic). All
cases and controls gave informed consent to participate in this study,
Table 6. Interaction between rs4911442 (near ASIP)
and MC1R effects on red hair color, and CMM risk
Joint
genotype
Cutaneous
Melanoma Red hair
MC1R rs4911442 Cases N
Odds
ratio Red Total Penetrance
R/R C/C 1 2 5.00 1 2 0.500
C/T 17 34 5.00 30 38 0.789
T/T 45 94 4.59 73 108 0.676
R/r C/C 3 11 1.88 5 12 0.417
C/T 27 60 4.09 12 74 0.162
T/T 73 226 2.55 13 250 0.052
R/w C/C 2 5 3.33 0 6 0.000
C/T 43 112 3.12 8 140 0.057
T/T 99 343 2.03 13 412 0.032
r/r C/C 3 5 7.50 0 5 0.000
C/T 20 35 6.67 2 39 0.051
T/T 19 83 1.48 0 100 0.000
r/w C/C 2 16 0.71 0 19 0.000
C/T 33 127 1.76 3 148 0.020
T/T 74 323 1.49 2 417 0.005
w/w C/C 2 2 24.81 0 3 0.000
C/T 24 101 1.56 0 135 0.000
T/T 52 312 1.00 0 412 0.000
ASIP, Agouti signaling protein; CMM, cutaneous malignant melanoma;
MC1R, melanocortin-1 receptor
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and the study protocol was approved by appropriate institutional
review boards and adhered to the Helsinki Guidelines.
Ancestry was measured by questioning either the individual or a
parent about the country of birth and ancestry of each of the
grandparents of the individual. As most subjects were of European
ancestry, we have constructed three ancestry scores on the basis of the
proportion of grandparents of Northern European (British, Scandina-
vian, Danish, Dutch, German, and French), Southern European
(Spanish, Italian, and Greek), and Eastern European ancestry. In
addition, the Northern indicator was supplemented by ‘‘Celtic’’
(Ireland, Scotland, and Wales), English, and Continental indicators, to
test whether there were further substructure effects. Ancestry data is
available for all cases and controls included in these analyses.
Genotyping and statistical analysis
We selected SNPs for association testing based on association with
pigmentation phenotypes in our own and other studies (Palmer et al.,
2000; Sturm et al., 2008; Sulem et al., 2007; Han et al., 2008). In the
case of SNPs near ASIP (Brown et al., 2008), we had observed
maximal association with CMM at SNPs away from ASIP itself,
hence the two SNPs reported to be most strongly associated to CMM
in the study of Gudbjartsson et al. (2008) were not genotyped. We
did not genotype within SLC24A5 (‘‘Golden’’), given that the variant
associated with human skin color is almost monomorphic in whites.
SNPs were typed using iPLEX Gold chemistry on a MALDI-TOF Mass
Spectrometer (Sequenom, San Diego, CA). PCR was carried out
using a 2.5-ml reaction mixture in standard 384-well plates. PCR was
performed using 10 ng genomic DNA, 0.5 unit of Taq polymerase
(HotStarTaq, Qiagen, Valencia, CA), 500 mmol of each dNTP, and
100 nmol of each PCR primer. PCR thermal cycling in an ABI-9700
instrument was 15 minutes at 94 1C, followed by 45 cycles of 20 sec
at 94 1C, 30 seconds at 56 1C, and 60 seconds at 72 1C. To the
completed PCR mixture, 1ml containing 0.15 units of Shrimp
alkaline phosphatase was added and the mixture incubated for
30 minutes at 37 1C followed by inactivation for 5 minutes at 85 1C.
After adjusting the concentrations of extension primers to equilibrate
signal-to-noise ratios, the post-PCR primer extension reaction of the
iPLEX assay was performed in a final 5 ml volume extension reaction
containing 0.1 ml of termination mix, 0.02ml of DNA polymerase
(Sequenom), and 600–1,200 nM extension primers. A two-step 200
short cycles program was used for the iPLEX reaction: initial
denaturation was 30 seconds at 94 1C followed by five cycles of
5 seconds at 52 1C and 5 seconds at 80 1C. An additional 40
annealing and extension cycles were then looped back to 5 seconds
at 94 1C, 5 seconds at 52 1C, and 5 seconds at 80 1C. The final
extension was carried out at 72 1C for 3 minutes and the sample was
cooled to 20 1C. The iPLEX reaction products were desalted by
diluting samples with 15 ml of water and adding 3 ml of resin, and
centrifuged to remove resin. The products were spotted on a
SpectroChip (Sequenom), processed, and analysed in a Compact
Mass Spectrometer using MassARRAY Workstation (version 3.3)
software (Sequenom). As genotyping has been carried out in various
subsets of the data, the number of genotyped cases and controls
varies from marker to marker. Specifically, some markers are
genotyped in the entire collection, whereas others have been
genotyped only in a nested sample of unrelated cases and controls.
As some cases (105 individuals) are from 48 multiplex families and
all our controls come from twin families, the association analyses
were carried out using Sib-pair 1.0 (Duffy, 2008). The association
analysis in Sib-pair implements a logistic regression penetrance
analysis of measured genotypes within pedigrees that may include
monozygotic twins, and uses Monte Carlo (gene-dropping) simulation
2.5
1.0
rs
17
30
56
57
rs
49
11
31
0
rs
22
53
33
5
rs
72
19
70
rs
72
66
30
0
rs
60
88
51
9
rs
60
88
52
0
rs
24
24
99
4
rs
91
08
73
rs
61
42
20
6
rs
29
16
71
rs
32
13
18
2
rs
20
71
05
4
rs
61
42
04
7
rs
17
09
14
05
rs
49
11
37
9
rs
60
59
59
2
rs
20
64
34
8
rs
22
84
37
8
rs
61
41
44
3
rs
13
04
33
92
rs
22
68
08
9
rs
81
91
63
rs
60
59
74
3
rs
81
91
62
rs
60
60
00
3
rs
95
98
29
rs
49
11
44
2
rs
72
71
28
9
rs
60
88
61
9
rs
18
85
12
0
rs
60
58
33
9
rs
12
04
55
2
3
7 2 2
2
0
0
3
1
1 5
0
2
0
1
0
0
7
0
0
6
1
4
1
0
3
2
0
0
0
0
0
1
2
0
0
0
5
0
8
0
5
6
6
1
5 1
40
6
0
6
6
7
2 3
3
2
6
1
0
3
6
0
7
2
6
4
0
1
8
1
7
2
0
2
0
6
0
6
0
6
7
1
0
7
9 4
5
9
3
1
2
11
56
12
24
55
28
94 39
20
95
20 10
30
10 30 17
12 97
17 42
4032
11
14
39
12
33
25 41
10
3
9
5
6
1
7
2
6
6
32
3
3
15
57
10
61
22
12
21
48
17
10
17
40 10
14
68
52
15
7
3 1
2
8
1
3
4
0 4
9
8
9
7
1
20
48
50 20
19
13 39
92
65
48
17
19
14
73
1359
29
2116
31
11
99
19
8
0
0
517
62
37
55
27
15
15
59
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
60
x$
0R
2[-
1]
2
Figure 1. Odds ratios for red hair color (red line) and cutaneous malignant melanoma (black line), and pairwise linkage disequilibrium (r2, with colors
generated using the ‘‘4 gamete rule’’) versus SNPs around Agouti signalling protein (ASIP). CMM, cutaneous malignant melanoma.
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to obtain P-values adjusted for the relationships of cases and controls.
Other analyses have been carried out in the R statistical analysis
environment (R Core Development Team, 2008), using especially the
haplo.stats package (Sinnwell et al., 2007), and also using Haploview
(Barrett et al., 2005) to generate plots and long-range haplotypes. We
express the overall contribution of the measured loci to risk of melanoma
in logistic regression analyses as the Nagelkerke R2 (Nagelkerke 1991),
and have also calculated the locus-specific sibling recurrence risk (James,
1971; Risch, 1990) predicted for that locus under an assumed lifetime
risk of 5.2% (Queensland Cancer Registry, 2008). This further assumes
that a proportional hazards model is appropriate, but is quite robust to
the assumed lifetime risk.
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